Exelixis (EXEL) Common Equity (2010 - 2026)

Exelixis' Common Equity history runs 17 years deep, the most recent figure standing at $1.9 billion for Q2 2026.

• On a quarterly basis, Common Equity fell 9.16% year-over-year to $1.9 billion in Q2 2026; TTM through Apr 2026 was $1.9 billion, a 9.16% decrease from a year earlier, with the FY2026 full-year figure at $2.2 billion, down 3.69% from the prior year.
• Common Equity eased to $1.9 billion in Q2 2026 per EXEL's latest filing, from $2.2 billion in the prior quarter.
• Across five years, Common Equity topped out at $2.6 billion in Q1 2023 and bottomed at $1.9 billion in Q2 2026.
• The 5-year median for Common Equity is $2.3 billion (2023), against an average of $2.3 billion.
• Across the five-year window, Common Equity grew 20.02% in 2022 and declined 16.72% in 2024, its largest moves.
• Year by year, Common Equity stood at $2.5 billion in 2022, then slipped by 9.02% to $2.3 billion in 2023, then advanced by 0.51% to $2.3 billion in 2024, then dropped by 5.04% to $2.2 billion in 2025, then dropped by 10.41% to $1.9 billion in 2026.
• Per Business Quant, the three latest EXEL Common Equity figures stand at $1.9 billion (Q2 2026), $2.2 billion (Q1 2026), and $2.2 billion (Q4 2025).